349 related articles for article (PubMed ID: 32415537)
1. Chemokines in Myocardial Infarction.
Chen B; Frangogiannis NG
J Cardiovasc Transl Res; 2021 Feb; 14(1):35-52. PubMed ID: 32415537
[TBL] [Abstract][Full Text] [Related]
2. Targeting the chemokines in cardiac repair.
Cavalera M; Frangogiannis NG
Curr Pharm Des; 2014; 20(12):1971-9. PubMed ID: 23844733
[TBL] [Abstract][Full Text] [Related]
3. CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans.
Saxena A; Bujak M; Frunza O; Dobaczewski M; Gonzalez-Quesada C; Lu B; Gerard C; Frangogiannis NG
Cardiovasc Res; 2014 Jul; 103(2):217-27. PubMed ID: 24891401
[TBL] [Abstract][Full Text] [Related]
4. The role of the chemokines in myocardial ischemia and reperfusion.
Frangogiannis NG
Curr Vasc Pharmacol; 2004 Apr; 2(2):163-74. PubMed ID: 15320517
[TBL] [Abstract][Full Text] [Related]
5. The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.
Cochain C; Auvynet C; Poupel L; Vilar J; Dumeau E; Richart A; Récalde A; Zouggari Y; Yin KY; Bruneval P; Renault G; Marchiol C; Bonnin P; Lévy B; Bonecchi R; Locati M; Combadière C; Silvestre JS
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2206-13. PubMed ID: 22796582
[TBL] [Abstract][Full Text] [Related]
6. Chemokines in cardiac fibrosis.
Li R; Frangogiannis NG
Curr Opin Physiol; 2021 Feb; 19():80-91. PubMed ID: 33195890
[TBL] [Abstract][Full Text] [Related]
7. Chemokines in the ischemic myocardium: from inflammation to fibrosis.
Frangogiannis NG
Inflamm Res; 2004 Nov; 53(11):585-95. PubMed ID: 15693606
[TBL] [Abstract][Full Text] [Related]
8. Chemokines in myocardial ischemia.
Frangogiannis NG; Entman ML
Trends Cardiovasc Med; 2005 Jul; 15(5):163-9. PubMed ID: 16165012
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling.
Bujak M; Dobaczewski M; Chatila K; Mendoza LH; Li N; Reddy A; Frangogiannis NG
Am J Pathol; 2008 Jul; 173(1):57-67. PubMed ID: 18535174
[TBL] [Abstract][Full Text] [Related]
10. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
Xia Y; Frangogiannis NG
Inflamm Allergy Drug Targets; 2007 Jun; 6(2):101-7. PubMed ID: 17692033
[TBL] [Abstract][Full Text] [Related]
11. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.
Bujak M; Ren G; Kweon HJ; Dobaczewski M; Reddy A; Taffet G; Wang XF; Frangogiannis NG
Circulation; 2007 Nov; 116(19):2127-38. PubMed ID: 17967775
[TBL] [Abstract][Full Text] [Related]
12. The inflammatory response in myocardial infarction.
Frangogiannis NG; Smith CW; Entman ML
Cardiovasc Res; 2002 Jan; 53(1):31-47. PubMed ID: 11744011
[TBL] [Abstract][Full Text] [Related]
13. Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.
Hilgendorf I; Frantz S; Frangogiannis NG
Circ Res; 2024 Jun; 134(12):1718-1751. PubMed ID: 38843294
[TBL] [Abstract][Full Text] [Related]
14. Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice.
Braunersreuther V; Montecucco F; Pelli G; Galan K; Proudfoot AE; Belin A; Vuilleumier N; Burger F; Lenglet S; Caffa I; Soncini D; Nencioni A; Vallée JP; Mach F
Thromb Haemost; 2013 Oct; 110(4):807-25. PubMed ID: 23925450
[TBL] [Abstract][Full Text] [Related]
15. Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.
Saxena A; Russo I; Frangogiannis NG
Transl Res; 2016 Jan; 167(1):152-66. PubMed ID: 26241027
[TBL] [Abstract][Full Text] [Related]
16. β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injury.
Grisanti LA; Traynham CJ; Repas AA; Gao E; Koch WJ; Tilley DG
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15126-15131. PubMed ID: 27956622
[TBL] [Abstract][Full Text] [Related]
17. Immune cells in repair of the infarcted myocardium.
Chen B; Frangogiannis NG
Microcirculation; 2017 Jan; 24(1):. PubMed ID: 27542099
[TBL] [Abstract][Full Text] [Related]
18. SDF-1α as a therapeutic stem cell homing factor in myocardial infarction.
Ghadge SK; Mühlstedt S; Ozcelik C; Bader M
Pharmacol Ther; 2011 Jan; 129(1):97-108. PubMed ID: 20965212
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the inflammatory response in cardiac repair.
Frangogiannis NG
Circ Res; 2012 Jan; 110(1):159-73. PubMed ID: 22223212
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
